Condition
Refractory Epilepsy in Children clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Refractory Epilepsy in Children clinical trials that are recruiting, at sites in 2 countries (most in China (1), Netherlands (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Cannabidiol as add-on therapy for children with refractory epilepsy (CBD-uN1que): an individualized N-of-1 series
This trial tests whether CBD oil helps reduce seizures in children with hard-to-treat epilepsy, using a series of personalized N-of-1 comparisons against a placebo.
-
Non-helium magnetoencephalography to find seizure sources in children with refractory epilepsy
This project will test whether non-helium magnetoencephalography (MEG) can help find the seizure source before surgery in children ages 3–18 whose epilepsy does not respond to medicines.
Related topics
Quick answers
How many Refractory Epilepsy in Children clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.